- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
-
Your selected country is
United States
- Change country/language
-
Promotions
-
sk-testpage
-
BD Primer Program
-
BD Discovery 2021
-
Reagents
-
DO NOT PUBLISH
-
Reagentes Com Valor Promocional
-
Lunch Box Giveaway
-
EQCプログラム 外部精度管理 施設間精度管理
-
Backbone Reagents Promo
-
Backbone Reagents Promo
-
Classic Dyes
-
Back to Lab
-
End of Year
-
Tcell Backbone Panel Promotion
-
BD Horizon™ Human T Cell Backbone Panel
-
New Lab Promotion
-
Flash Sale
-
BD Panel Design Program
-
Real Dyes Sample Offer
-
BD’s 50 Years of Innovation Research Instrument Promotion
-
BD FACSLyric™ Flow Cytometers 50th Anniversary Promo
-
BD FACSAria™ Customer Loyalty Promotion
-
FlowJo™ Software Promotion
-
BD® Research Cloud Promotion
-
sk-testpage
-
Custom BD® AbSeq
-
Custom AbSeq FAQ Answer 2
-
Custom AbSeq FAQ Answer 3
-
Custom AbSeq FAQ Answer 4
-
Custom AbSeq FAQ Answer 5
-
Custom AbSeq FAQ Answer 6
-
Custom AbSeq FAQ Answer 7
-
Custom AbSeq FAQ Answer 8
-
Custom AbSeq FAQ Answer 9
-
Custom AbSeq FAQ Answer 10
-
Custom AbSeq FAQ Answer 11
-
Custom AbSeq FAQ Answer 12
-
Custom AbSeq FAQ Answer 13
-
Custom AbSeq FAQ Answer 14
-
Custom AbSeq FAQ Answer 15
-
Custom AbSeq FAQ Answer 16
-
Custom AbSeq FAQ Answer 17
-
Custom AbSeq FAQ Answer 18
-
Custom AbSeq FAQ Answer 19
-
Custom AbSeq FAQ Answer 20
-
Custom AbSeq FAQ Answer 2
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- Change country/language
Old Browser
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Looks like you're visiting us from {{countryName}}.
Would you like to remain on the current country site or be redirected to one based on your location?
live copy GB
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
The First OMIP Panel to Profile NK Cells From Tumour Tissue
The History of NK cells in Immuno-oncology
NK cells (natural killer cells) have been a focus in immuno-oncology for decades, largely due to their ability to destroy tumour cells through spontaneous cytotoxicity, as well as their production of cytokines and chemokines that can help recruit additional immune cells.
More recent studies have shown that tumour progression and outcomes correlate with the presence of NK cells at the tumour site, making their study important from a therapeutic perspective.
Learn more about NK cells and their role in immuno-oncology.
The OMIP Panel Design
NK cells are notoriously difficult to study due to the limited amount of tissue that is normally available from tumour resections or biopsies.
This OMIP panel (Optimised Multicolour Immunophenotyping Panel) from Frutoso et al. takes a flow cytometry immunophenotyping approach in order to extract as much information as possible from a single-cell suspension with the goal of providing an in-depth characterisation of human NK cells.
Though other OMIP panels investigate these immune cells in a broader way (namely from human peripheral blood), this is the first specifically designed to profile NK cells isolated from tumour tissues.
Frutoso et al. combined collagenase Type II and DNase for tissue digestion in preparing the high-viability single-cell suspension, which yielded a good population of viable mucosal mononuclear cells when used with human mucosal tissues.
However, they found that detection of CD56, a biomarker typically used to identify NK cells, was affected substantially by the collagenase‐based tissue digestion. Thus, the panel is centred around the expression of NKp46, characterised as a highly conserved natural cytotoxicity receptor (NCR).
For the flow cytometry immunophenotyping, the team used a 27-colour phenotypic OMIP panel to identify NK cell activity and types. They compiled 18 biomarkers to assess NK cell function, including maturation, differentiation, migration, homing potential and functional state.
Learn more about flow cytometry panel design.
Performance of the OMIP Panel in Phenotyping NK cells
Even if it wasn’t in the original OMIP panel goal, most biomarker expressions in this OMIP panel could be assessed for CD3+ T cells to help provide greater biological insights.
The team concluded that this specific combination of biomarkers and the flow cytometry immunophenotyping approach provided a thorough characterisation of NK cells within tumour tissues and could prove to be a valuable tool in the study of immune cell function in human tours and mucosal tissues.
Read the full study to learn more about this 27-colour OMIP panel.
References
1. Frutoso, M, Mair F, and Prlic M. OMIP‐070: NKp46‐Based 27‐Color Phenotyping to Define Natural Killer Cells Isolated From Human Tumor Tissues. Cytometry A. 2020 Oct; 97(10): 1052–1056. doi: 10.1002/cyto.a.24230. Epub 2020 Oct 8.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.